Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of p28 (Cell Penetrating Peptide) in the Treatment of Refractory Solid Tumors

NCT00914914 is registered in ClinicalTrials.gov with Dr. Tapas K. Das Gupta as lead sponsor.

NCT NCT00914914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00914914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of p28 (Cell Penetrating Peptide) in the Treatment of Refractory Solid Tumors
Lead sponsor
Dr. Tapas K. Das Gupta
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2009
Completion date
June 30, 2011
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory solid tumors